Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Recursion Pharmaceuticals, Inc.
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
August 08, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
EXAI
RXRX
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day
June 24, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RXRX
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
April 16, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Plans to Open New Office in London
March 11, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RXRX
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
January 04, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RXRX
Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology
November 09, 2023
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
RXRX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.